• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

胆管癌细胞引导脂肪酸以支持膜合成并调节巨噬细胞表型。

Cholangiocarcinoma cells direct fatty acids to support membrane synthesis and modulate macrophage phenotype.

作者信息

Dei Cas Michele, Mantovani Stefania, Oliviero Barbara, Zulueta Aida, Montavoci Linda, Falleni Monica, Tosi Delfina, Morano Camillo, Penati Sara, Chiocchetti Annalisa, Sinella Riccardo, Barbero Mazzucca Camilla, Donadon Matteo, Soldani Cristiana, Piccolo Gaetano, Barabino Matteo, Bianchi Paolo Pietro, Maestri Marcello, Lleo Ana, Banales Jesus M, Mondelli Mario U, Caretti Anna

机构信息

Department of Health Sciences, University of Milan, Milan, Italy.

Research Department, Division of Clinical Immunology-Infectious Diseases, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.

出版信息

Hepatol Commun. 2025 May 23;9(6). doi: 10.1097/HC9.0000000000000717. eCollection 2025 Jun 1.

DOI:10.1097/HC9.0000000000000717
PMID:40408281
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12106197/
Abstract

BACKGROUND AND AIMS

Cholangiocarcinoma (CCA) is a globally rare, increasingly incident cancer. Metabolic reprogramming is common in cancer cells, and altered lipid homeostasis favors tumor development and progression. Previous studies have described lipid deregulation in HCC cells, while in CCA, the lipidome profile is still poorly characterized.

METHODS

We used liquid chromatography-tandem mass spectrometry to examine the lipid level profile of intrahepatic CCA (iCCA) and non-tumor surrounding tissue from patients, as well as in patients' and healthy controls' sera.

RESULTS

All lipid classes were upregulated in tumor specimens and iCCA-derived sera. Newly synthesized fatty acids (FAs) accumulated in iCCA and were only marginally directed to mitochondrial β-oxidation and scarcely folded in lipid droplets as neutral species. Metabolic flux assay showed that FAs were instead redirected toward plasma membrane formation and remodeling, being incorporated into phospholipids and sphingomyelin. A distinct lipid droplet and macrophage distribution was revealed by immunohistochemistry and Imaging Mass Cytometry. Lipid droplets were fewer in iCCA than in normal tissue and present mainly in the intratumoral fibrous septa and in M2 macrophages. Monocytes modified their lipid content and phenotype in the presence of iCCA cells, and the same effect could be recapitulated by FA supplementation.

CONCLUSIONS

Our results reveal a profound alteration in the lipid content of iCCA tissues and demonstrate that FA accumulation prompts iCCA aggressiveness by supporting membrane biogenesis, generating bioactive lipids that boost proliferation, and by modifying macrophage phenotype.

摘要

背景与目的

胆管癌(CCA)是一种全球范围内罕见且发病率日益上升的癌症。代谢重编程在癌细胞中很常见,脂质稳态的改变有利于肿瘤的发生和发展。先前的研究描述了肝癌细胞中的脂质失调,而在CCA中,脂质组谱仍未得到充分表征。

方法

我们使用液相色谱 - 串联质谱法检测了患者肝内CCA(iCCA)和非肿瘤周围组织以及患者和健康对照血清中的脂质水平谱。

结果

所有脂质类别在肿瘤标本和iCCA衍生血清中均上调。新合成的脂肪酸(FAs)在iCCA中积累,仅少量导向线粒体β-氧化,几乎没有以中性物质形式折叠在脂滴中。代谢通量分析表明,FAs反而重新导向质膜形成和重塑,被整合到磷脂和鞘磷脂中。免疫组织化学和成像质谱流式细胞术揭示了独特的脂滴和巨噬细胞分布。iCCA中的脂滴比正常组织中的少,主要存在于瘤内纤维间隔和M2巨噬细胞中。单核细胞在iCCA细胞存在下改变其脂质含量和表型,补充FA也可重现相同效果。

结论

我们的结果揭示了iCCA组织脂质含量的深刻改变,并表明FA积累通过支持膜生物发生、产生促进增殖的生物活性脂质以及改变巨噬细胞表型来促进iCCA的侵袭性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae49/12106197/fb6492f34e78/hc9-9-e0717-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae49/12106197/72d25cb05ba4/hc9-9-e0717-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae49/12106197/51640e8c65ce/hc9-9-e0717-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae49/12106197/7cdc0521bcd8/hc9-9-e0717-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae49/12106197/3ba4560eada0/hc9-9-e0717-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae49/12106197/034dcc020c0f/hc9-9-e0717-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae49/12106197/dceacab7698c/hc9-9-e0717-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae49/12106197/aa0676a9b3b6/hc9-9-e0717-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae49/12106197/a801a5321168/hc9-9-e0717-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae49/12106197/fb6492f34e78/hc9-9-e0717-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae49/12106197/72d25cb05ba4/hc9-9-e0717-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae49/12106197/51640e8c65ce/hc9-9-e0717-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae49/12106197/7cdc0521bcd8/hc9-9-e0717-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae49/12106197/3ba4560eada0/hc9-9-e0717-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae49/12106197/034dcc020c0f/hc9-9-e0717-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae49/12106197/dceacab7698c/hc9-9-e0717-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae49/12106197/aa0676a9b3b6/hc9-9-e0717-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae49/12106197/a801a5321168/hc9-9-e0717-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae49/12106197/fb6492f34e78/hc9-9-e0717-g009.jpg

相似文献

1
Cholangiocarcinoma cells direct fatty acids to support membrane synthesis and modulate macrophage phenotype.胆管癌细胞引导脂肪酸以支持膜合成并调节巨噬细胞表型。
Hepatol Commun. 2025 May 23;9(6). doi: 10.1097/HC9.0000000000000717. eCollection 2025 Jun 1.
2
FASN-mediated fatty acid biosynthesis remodels immune environment in Clonorchis sinensis infection-related intrahepatic cholangiocarcinoma.FASN 介导的脂肪酸生物合成重塑肝内胆管癌相关感染性华支睾吸虫病的免疫微环境。
J Hepatol. 2024 Aug;81(2):265-277. doi: 10.1016/j.jhep.2024.03.016. Epub 2024 Mar 19.
3
Revealing the role of necroptosis microenvironment: FCGBP + tumor-associated macrophages drive primary liver cancer differentiation towards cHCC-CCA or iCCA.揭示坏死性凋亡微环境的作用:FCGBP+肿瘤相关巨噬细胞驱动原发性肝癌向胆管细胞型肝细胞癌或肝内胆管癌分化。
Apoptosis. 2024 Apr;29(3-4):460-481. doi: 10.1007/s10495-023-01908-3. Epub 2023 Nov 28.
4
Ceramide present in cholangiocarcinoma-derived extracellular vesicle induces a pro-inflammatory state in monocytes.胆管癌来源的细胞外囊泡中的神经酰胺诱导单核细胞产生促炎状态。
Sci Rep. 2023 May 12;13(1):7766. doi: 10.1038/s41598-023-34676-w.
5
New molecular mechanisms in cholangiocarcinoma: signals triggering interleukin-6 production in tumor cells and KRAS co-opted epigenetic mediators driving metabolic reprogramming.胆管癌中的新分子机制:触发肿瘤细胞产生白细胞介素 6 的信号以及 KRAS 挪用的表观遗传介质驱动代谢重编程。
J Exp Clin Cancer Res. 2022 May 26;41(1):183. doi: 10.1186/s13046-022-02386-2.
6
Altered fatty acid metabolism rewires cholangiocarcinoma stemness features.脂肪酸代谢改变重塑胆管癌干性特征。
JHEP Rep. 2024 Aug 6;6(10):101182. doi: 10.1016/j.jhepr.2024.101182. eCollection 2024 Oct.
7
Tumor ratio of unsaturated to saturated sulfatide species is associated with disease-free survival in intrahepatic cholangiocarcinoma.肿瘤中不饱和与饱和硫酸化神经酰胺种类的比值与肝内胆管癌的无病生存相关。
Cell Oncol (Dordr). 2023 Jun;46(3):629-642. doi: 10.1007/s13402-022-00766-6. Epub 2023 Jan 11.
8
Different iron-handling in inflamed small and large cholangiocytes and in small and large-duct type intrahepatic cholangiocarcinoma.炎症状态下的小、大胆管细胞和小、大导管型肝内胆管癌中铁处理的不同。
Eur J Histochem. 2020 Oct 19;64(4):3156. doi: 10.4081/ejh.2020.3156.
9
Is nestin a diagnostic marker for combined hepatocellular-cholangiocarcinoma?巢蛋白是否可作为肝细胞胆管细胞癌的诊断标志物?
Histopathology. 2022 Apr;80(5):859-868. doi: 10.1111/his.14622. Epub 2022 Mar 3.
10
Membrane RRM2-positive cells represent a malignant population with cancer stem cell features in intrahepatic cholangiocarcinoma.膜 RRM2 阳性细胞代表肝内胆管癌中具有癌症干细胞特征的恶性群体。
J Exp Clin Cancer Res. 2024 Sep 6;43(1):255. doi: 10.1186/s13046-024-03174-w.

引用本文的文献

1
Lipid Metabolism Reprogramming in Tumor-Associated Macrophages Modulates Their Function in Primary Liver Cancers.肿瘤相关巨噬细胞中的脂质代谢重编程调节其在原发性肝癌中的功能。
Cancers (Basel). 2025 May 31;17(11):1858. doi: 10.3390/cancers17111858.

本文引用的文献

1
Sphingolipid metabolism and complement signaling in cancer progression.鞘脂代谢与癌症进展中的补体信号通路
Trends Cancer. 2023 Oct;9(10):782-787. doi: 10.1016/j.trecan.2023.07.001. Epub 2023 Jul 26.
2
Beyond energy provider: multifunction of lipid droplets in embryonic development.超越能源提供者:脂滴在胚胎发育中的多功能性。
Biol Res. 2023 Jul 12;56(1):38. doi: 10.1186/s40659-023-00449-y.
3
Proteomics of immune cells from liver tumors reveals immunotherapy targets.肝癌免疫细胞的蛋白质组学揭示免疫治疗靶点。
Cell Genom. 2023 May 30;3(6):100331. doi: 10.1016/j.xgen.2023.100331. eCollection 2023 Jun 14.
4
Sphingosine-1-phosphate and its receptors in vascular endothelial and lymphatic barrier function.鞘氨醇-1-磷酸及其受体在血管内皮和淋巴屏障功能中的作用。
J Biol Chem. 2023 Jun;299(6):104775. doi: 10.1016/j.jbc.2023.104775. Epub 2023 May 2.
5
EASL-ILCA Clinical Practice Guidelines on the management of intrahepatic cholangiocarcinoma.欧洲肝脏研究学会-国际肝脏癌症协会《肝内胆管癌管理临床实践指南》。
J Hepatol. 2023 Jul;79(1):181-208. doi: 10.1016/j.jhep.2023.03.010. Epub 2023 Apr 20.
6
Repurposing a tricyclic antidepressant in tumor and metabolism disease treatment through fatty acid uptake inhibition.通过抑制脂肪酸摄取来重新利用三环抗抑郁药治疗肿瘤和代谢疾病。
J Exp Med. 2023 Mar 6;220(3). doi: 10.1084/jem.20221316. Epub 2022 Dec 15.
7
Long-Chain Acylcarnitines Induce Senescence of Invariant Natural Killer T Cells in Hepatocellular Carcinoma.长链酰基辅酶 A 诱导肝癌中固有自然杀伤 T 细胞衰老。
Cancer Res. 2023 Feb 15;83(4):582-594. doi: 10.1158/0008-5472.CAN-22-2273.
8
Mitochondrial Fatty Acid β-Oxidation Disorders: From Disease to Lipidomic Studies-A Critical Review.线粒体脂肪酸 β-氧化障碍:从疾病到脂质组学研究——综述。
Int J Mol Sci. 2022 Nov 11;23(22):13933. doi: 10.3390/ijms232213933.
9
Stearoyl-CoA desaturase 1 as a therapeutic target for cancer: a focus on hepatocellular carcinoma.硬脂酰辅酶 A 去饱和酶 1 作为癌症的治疗靶点:以肝细胞癌为重点。
Mol Biol Rep. 2022 Sep;49(9):8871-8882. doi: 10.1007/s11033-021-07094-2. Epub 2022 Jul 29.
10
Acetyl-Coenzyme A Synthetase 2 Potentiates Macropinocytosis and Muscle Wasting Through Metabolic Reprogramming in Pancreatic Cancer.乙酰辅酶 A 合成酶 2 通过代谢重编程增强胰腺癌中的巨胞饮作用和肌肉消耗。
Gastroenterology. 2022 Nov;163(5):1281-1293.e1. doi: 10.1053/j.gastro.2022.06.058. Epub 2022 Jun 28.